Uganda: ACT treatment is too expensive
The article below was contributed by journalist Hope Mafaranga (Uganda) as part of the SjCOOP project in collaboration with MalariaWorld.
The government of Uganda wants people to use Artemisinin Combination Therapy (ACT) for treating malaria but the treatment is too expensive and there’s not enough available of this medicine. 
Cost burdens are the product of complex relationships between social, economic and epidemiological factors. The cost data presented in this study reflect transmission patterns in the four districts, suggesting that a relationship between costs burdens and the nature of transmission might exist, and that the same warrants more attention from researchers and policy makers.